RxDoctor Payments Data

Marissa Anderson, MD

Colon & Rectal Surgery · Chicago, ILNPI 1043539836

Payments from drug & device makers

What this record shows

19 manufacturers reported payments, led by Intuitive Surgical at 35.7% of the total. Reporting peaked in 2019 at $1,910 and has fallen 92.1% since, to $151 in 2025.

$4,449in general payments, 2019–2025

Across 53 payments — averaging $83.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Stryker$843
  • Medtronic$487
  • Baxter Healthcare$381
  • Conmed Corporation$217
  • Axonics, Inc.$165
  • plus $766 from 13 others

What the payments were for

  • Travel & lodging$2,11848%
  • Food & beverage$2,33152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,449 in reported general payments places this provider in the 55th percentile of 79 colon & rectal surgery providers in Illinois.

See all colon & rectal surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$69,784
Medicare patients
125
Services billed
287

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates22$1,443
Hydrocortisone17$290
Neomycin Sulfate24$70
Metronidazole24$23
Prochlorperazine Maleate15$12

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →